Market Overview

Smith & Nephew To Acquire ArthroCare For $1.7B

Related SNN
Smith & Nephew Downgraded By Barclays, Expects Management Transition To Delay Key Initiatives
UBS Downgrades Smith & Nephew, Says Margin Upside 'Elusive'
Related ARTC
ArthroCare Q1 Earnings Miss Ests; Revs In Line - Analyst Blog
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews

Smith & Nephew PLC (NYSE: SNN) announced its plans to buy ArthroCare (NASDAQ: ARTC) for $1.7 billion in cash.

Smith & Nephew will pay $48.25 per share in cash to acquire ArthroCare, representing a 6.3% premium to ArthroCare's closing shares price on January 31.

ArthroCare shares fell 0.46% to close at $45.38 on Friday.

Posted-In: merger and acquisitionNews M&A


Related Articles (SNN + ARTC)

View Comments and Join the Discussion!